[HTML][HTML] Molecular targeted therapy for anticancer treatment

HY Min, HY Lee - Experimental & molecular medicine, 2022 - nature.com
Since the initial clinical approval in the late 1990s and remarkable anticancer effects for
certain types of cancer, molecular targeted therapy utilizing small molecule agents or …

Molecular targeted therapy for anticancer treatment

HY Min, HY Lee - Experimental & Molecular Medicine, 2022 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Since the initial clinical approval in the late
1990s and remarkable anticancer effects for certain types of cancer, molecular targeted …

Molecular targeted therapy for anticancer treatment.

HY Min, HY Lee - Experimental & Molecular Medicine, 2022 - europepmc.org
Since the initial clinical approval in the late 1990s and remarkable anticancer effects for
certain types of cancer, molecular targeted therapy utilizing small molecule agents or …

Molecular targeted therapy for anticancer treatment

HY Min, HY Lee - Experimental & molecular medicine, 2022 - pubmed.ncbi.nlm.nih.gov
Since the initial clinical approval in the late 1990s and remarkable anticancer effects for
certain types of cancer, molecular targeted therapy utilizing small molecule agents or …

Molecular targeted therapy for anticancer treatment

HY Min, HY Lee - Experimental & Molecular Medicine, 2022 - search.proquest.com
Since the initial clinical approval in the late 1990s and remarkable anticancer effects for
certain types of cancer, molecular targeted therapy utilizing small molecule agents or …

[HTML][HTML] Molecular targeted therapy for anticancer treatment

HY Min, HY Lee - Experimental & Molecular Medicine, 2022 - ncbi.nlm.nih.gov
Since the initial clinical approval in the late 1990s and remarkable anticancer effects for
certain types of cancer, molecular targeted therapy utilizing small molecule agents or …

Molecular targeted therapy for anticancer treatment.

HY Min, HY Lee - Experimental & Molecular Medicine, 2022 - europepmc.org
Since the initial clinical approval in the late 1990s and remarkable anticancer effects for
certain types of cancer, molecular targeted therapy utilizing small molecule agents or …